Guest guest Posted May 29, 2009 Report Share Posted May 29, 2009 I found theses articles that you may be interested in: " While Americans are going ga-ga with their new anticancer drug " Glivec " - that was featured on the cover of May 28 issue of Time magazine - the low-profile, cash-strapped Kolkata researchers have been working quietly for over a decade shunning publicity until they obtained proof from human trials nine weeks ago. " " Most remarkable fact, according to the scientists was that Methylglyoxal was successful against different types of cancer unlike " Glivec " which targets only the CHRONIC MYELOID LEUKEMIA. " Those whose health returned to " excellent " condition after treatment with Methylglyoxal included patients in " a very advanced stages " of colon cancer, acute myeloid leukemia, non-Hodgkin's lymphoma, and cancers of ovary, breast, liver, lung, bone, gall bladder, pancreas and oral cavity. " Entire article can be found at this website: http://articles.mercola.com/sites/articles/archive/2001/06/13/methylglyoxal.aspx ************************************** Found at Ralph Moss's CancerDecisions.com (Hyderabaad, May 28) INDIAN CANCER researchers have taken a giant step on the road to discovering the ultimate cancer cure by developing a drug that selectively targets the cancer cells without harming the healthy ones. Researchers in Calcutta claim that patients in " very advanced stages " of cancer for whom all other treatments had failed have been brought back to " excellent " health with the help of a drug formulation they have developed after research spanning more than a decade. " We have what we think magic bullet against cancer, " says Manju Ray, a biochemist at the Indian Association of the Cultivation of Science (IACS) where the drug was developed under a project funded by the Department of Science and Technology and the Council of Scientific and Industrial Research. Most currently available anti-cancer drugs are toxic because they also damage the normal cells. Ray says the IACS formulation, containing " Methylglyoxal " as the lead ingredient, combats only the diseased cells, the cherished goal of cancer researchers worldwide. Methylglyoxal is a metabolite in the human body produced during glucose breakdown. Entire article can be found at this website: http://www.vitamincfoundation.org/goxy.htm FYI, Lottie Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 4, 2009 Report Share Posted June 4, 2009 Hi Lottie, Just a reminder that Gleevec targets more than CML. Just as the GIST patients who are alive today. Zavie Zavie (age 70) 67 Shoreham Avenue Ottawa, Canada, K2G 3X3 dxd AUG/99 INF OCT/99 to FEB/00, CHF No meds FEB/00 to JAN/01 Gleevec since MAR/27/01 (400 mg) CCR SEP/01. #102 in Zero Club 2.8 log reduction Sep/05 3.0 log reduction Jan/06 2.9 log reduction Feb/07 3.6 log reduction Apr/08 3.6 log reduction Sep/08 e-mail: zmiller@... Tel: 613-726-1117 Fax: 613-482-4801 Cell: 613-282-0204 ID: zaviem YM: zaviemiller Skype: Zavie _____ From: [mailto: ] On Behalf Of Lottie Duthu Sent: May-28-09 7:24 PM CML Subject: [ ] Could this be the answer or junk science? I found theses articles that you may be interested in: " While Americans are going ga-ga with their new anticancer drug " Glivec " - that was featured on the cover of May 28 issue of Time magazine - the low-profile, cash-strapped Kolkata researchers have been working quietly for over a decade shunning publicity until they obtained proof from human trials nine weeks ago. " " Most remarkable fact, according to the scientists was that Methylglyoxal was successful against different types of cancer unlike " Glivec " which targets only the CHRONIC MYELOID LEUKEMIA. " Those whose health returned to " excellent " condition after treatment with Methylglyoxal included patients in " a very advanced stages " of colon cancer, acute myeloid leukemia, non-Hodgkin's lymphoma, and cancers of ovary, breast, liver, lung, bone, gall bladder, pancreas and oral cavity. " Entire article can be found at this website: http://articles. <http://articles.mercola.com/sites/articles/archive/2001/06/13/methylglyoxal ..aspx> mercola.com/sites/articles/archive/2001/06/13/methylglyoxal.aspx ************************************** Found at Ralph Moss's CancerDecisions.com (Hyderabaad, May 28) INDIAN CANCER researchers have taken a giant step on the road to discovering the ultimate cancer cure by developing a drug that selectively targets the cancer cells without harming the healthy ones. Researchers in Calcutta claim that patients in " very advanced stages " of cancer for whom all other treatments had failed have been brought back to " excellent " health with the help of a drug formulation they have developed after research spanning more than a decade. " We have what we think magic bullet against cancer, " says Manju Ray, a biochemist at the Indian Association of the Cultivation of Science (IACS) where the drug was developed under a project funded by the Department of Science and Technology and the Council of Scientific and Industrial Research. Most currently available anti-cancer drugs are toxic because they also damage the normal cells. Ray says the IACS formulation, containing " Methylglyoxal " as the lead ingredient, combats only the diseased cells, the cherished goal of cancer researchers worldwide. Methylglyoxal is a metabolite in the human body produced during glucose breakdown. Entire article can be found at this website: http://www.vitaminc <http://www.vitamincfoundation.org/goxy.htm> foundation.org/goxy.htm FYI, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.